Site-selective modification strategies in antibody–drug conjugates
Antibody–drug conjugates (ADCs) harness the highly specific targeting capabilities of an
antibody to deliver a cytotoxic payload to specific cell types. They have garnered …
antibody to deliver a cytotoxic payload to specific cell types. They have garnered …
Enzymes as green catalysts for precision macromolecular synthesis
S Shoda, H Uyama, J Kadokawa, S Kimura… - Chemical …, 2016 - ACS Publications
The present article comprehensively reviews the macromolecular synthesis using enzymes
as catalysts. Among the six main classes of enzymes, the three classes, oxidoreductases …
as catalysts. Among the six main classes of enzymes, the three classes, oxidoreductases …
Characterization of therapeutic antibodies and related products
Here, we review the current state of the art in analytical and structural methods used to
characterize therapeutic monoclonal antibodies (mAbs) and derivatives. First, a general …
characterize therapeutic monoclonal antibodies (mAbs) and derivatives. First, a general …
Emerging principles for the therapeutic exploitation of glycosylation
Background Glycoproteins and glycolipids exist as an ensemble of glycosylated variants, or
glycoforms. Specific glycoforms are directly modulated by microenvironmental cues and play …
glycoforms. Specific glycoforms are directly modulated by microenvironmental cues and play …
Chemoenzymatic methods for the synthesis of glycoproteins
C Li, LX Wang - Chemical reviews, 2018 - ACS Publications
Glycosylation is one of the most prevalent posttranslational modifications that profoundly
affects the structure and functions of proteins in a wide variety of biological recognition …
affects the structure and functions of proteins in a wide variety of biological recognition …
Oligosaccharide synthesis and translational innovation
The translation of biological glycosylation in humans to the clinical applications involves
systematic studies using homogeneous samples of oligosaccharides and glycoconjugates …
systematic studies using homogeneous samples of oligosaccharides and glycoconjugates …
Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions
The fine structures of Fc N-glycans can modulate the effector functions of IgG antibodies. It
has been demonstrated that lack of the core fucose on the Fc N-glycans leads to drastic …
has been demonstrated that lack of the core fucose on the Fc N-glycans leads to drastic …
Chemoenzymatic conjugation of toxic payloads to the globally conserved N-glycan of native mAbs provides homogeneous and highly efficacious antibody–drug …
R Van Geel, MA Wijdeven, R Heesbeen… - Bioconjugate …, 2015 - ACS Publications
A robust, generally applicable, nongenetic technology is presented to convert monoclonal
antibodies into stable and homogeneous ADCs. Starting from a native (nonengineered) …
antibodies into stable and homogeneous ADCs. Starting from a native (nonengineered) …
A common glycan structure on immunoglobulin G for enhancement of effector functions
CW Lin, MH Tsai, ST Li, TI Tsai… - Proceedings of the …, 2015 - National Acad Sciences
Antibodies have been developed as therapeutic agents for the treatment of cancer, infection,
and inflammation. In addition to binding activity toward the target, antibodies also exhibit …
and inflammation. In addition to binding activity toward the target, antibodies also exhibit …
The ENGases: versatile biocatalysts for the production of homogeneous N-linked glycopeptides and glycoproteins
AJ Fairbanks - Chemical Society Reviews, 2017 - pubs.rsc.org
The endo-β-N-acetylglucosaminidases (ENGases) are an enzyme class (EC 3.2. 1.96)
produced by a range of organisms, ranging from bacteria, through fungi, to higher order …
produced by a range of organisms, ranging from bacteria, through fungi, to higher order …